Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons

被引:31
作者
Stumpf, Alexander [1 ]
Parthier, Daniel [1 ]
Sammons, Rosanna P. [1 ]
Stempel, A. Vanessa [1 ,2 ]
Breustedt, Joerg [1 ]
Rost, Benjamin R. [1 ,3 ]
Schmitz, Dietmar [1 ,3 ,4 ,5 ,6 ,7 ]
机构
[1] Charite Univ Med Berlin, Neurosci Res Ctr, Berlin, Germany
[2] UCL, Sainsbury Wellcome Ctr Neural Circuits & Behav, London, England
[3] German Ctr Neurodegenerat Dis DZNE, Berlin, Germany
[4] Berlin Inst Hlth, Berlin, Germany
[5] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany
[6] Cluster Excellence NeuroCure, Berlin, Germany
[7] Einstein Ctr Neurosci, Berlin, Germany
关键词
Cannabinoid Receptor type 2; Electrophysiology; Endocannabinoids; Somatosensory cortex; Slow self-inhibition; DRIVEN RAT MODELS; CB2; RECEPTOR; ENDOGENOUS CANNABINOIDS; SYNAPTIC-TRANSMISSION; PARKINSONS-DISEASE; PYRAMIDAL NEURONS; UP-REGULATION; MICE; ENDOCANNABINOIDS; ACTIVATION;
D O I
10.1016/j.neuropharm.2018.07.020
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Endogenous cannabinoids are diffusible lipid ligands of the main cannabinoid receptors type 1 and 2 (CB1R and CB2R). In the central nervous system endocannabinoids are produced in an activity-dependent manner and have been identified as retrograde modulators of synaptic transmission. Additionally, some neurons display a cell-autonomous slow self-inhibition (SSI) mediated by endocannabinoids. In these neurons, repetitive action potential firing triggers the production of endocannabinoids, which induce a long-lasting hyperpolarization of the membrane potential, rendering the cells less excitable. Different endocannabinoid receptors and effector mechanisms have been described underlying SSI in different cell types and brain areas. Here, we investigate SSI in neurons of layer 2/3 in the somatosensory cortex. High frequency bursts of action potentials induced SSI in pyramidal cells (PC) and regular spiking non pyramidal cells (RSNPC), but not in fast-spiking interneurons (FS). In RSNPCs the hyperpolarization was accompanied by a change in input resistance due to the activation of G protein-coupled inward rectifying K+ (GIRK) channels. A CB2R-specific agonist induced the long-lasting hyperpolarization, whereas preincubation with a CB2R-specific inverse agonist suppressed SSI. Additionally, using cannabinoid receptor knockout mice, we found that SSI was still intact in CB1R-deficient but abolished in CB2R-deficient mice. Taken together, we describe an additional SSI mechanism in which the activity-induced release of endocannabinoids activates GIRK channels via CB(2)Rs. These findings expand our knowledge about cell type-specific differential neuronal cannabinoid receptor signaling and suggest CB2R-selective compounds as potential therapeutic approaches. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:217 / 225
页数:9
相关论文
共 52 条
[1]  
Arey BJ, 2014, BIASED SIGNALING PHY, DOI [10.1016/B978-0-12-411460-9,00012-4., DOI 10.1016/B978-0-12-411460-9,00012-4]
[2]   Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 Ligands [J].
Atwood, Brady K. ;
Wager-Miller, James ;
Haskins, Christopher ;
Straiker, Alex ;
Mackie, Ken .
MOLECULAR PHARMACOLOGY, 2012, 81 (02) :250-263
[3]   Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids [J].
Bacci, A ;
Huguenard, JR ;
Prince, DA .
NATURE, 2004, 431 (7006) :312-316
[4]  
Benito C, 2003, J NEUROSCI, V23, P11136
[5]   Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor [J].
Buckley , NE ;
McCoy, KL ;
Mezey, É ;
Bonner, T ;
Zimmer, A ;
Felder, CC ;
Glass, M ;
Zimmer, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 396 (2-3) :141-149
[6]   Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation [J].
Carlisle, SJ ;
Marciano-Cabral, F ;
Staab, A ;
Ludwick, C ;
Cabral, GA .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2002, 2 (01) :69-82
[7]   Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina [J].
Cecyre, Bruno ;
Thomas, Sebastien ;
Ptito, Maurice ;
Casanova, Christian ;
Bouchard, Jean-Francois .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 (02) :175-184
[8]   Brain cannabinoid receptor 2: expression, function and modulation [J].
Chen, De-Jie ;
Gao, Ming ;
Gao, Fen-Fei ;
Su, Quan-Xi ;
Wu, Jie .
ACTA PHARMACOLOGICA SINICA, 2017, 38 (03) :312-316
[9]   Heterosynaptic LTD of hippocampal GABAergic synapses: A novel role of endocannabinoids in regulating excitability [J].
Chevaleyre, V ;
Castillo, PE .
NEURON, 2003, 38 (03) :461-472
[10]   Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease [J].
Concannon, Ruth M. ;
Okine, Bright N. ;
Finn, David P. ;
Dowd, Eilis .
EXPERIMENTAL NEUROLOGY, 2016, 283 :204-212